Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02863965
Other study ID # 2016SDU-QILU-13
Secondary ID
Status Recruiting
Phase N/A
First received July 30, 2016
Last updated August 8, 2016
Start date March 2016

Study information

Verified date July 2016
Source Shandong University
Contact Yanqing Li, PhD. MD.
Phone 18678827666
Email liyanqing@sdu.edu.cn
Is FDA regulated No
Health authority China: National Health and Family Planning Commission
Study type Observational

Clinical Trial Summary

The aim of the study is to evaluate the diagnostic value of high definition endoscopy and optic enhancement in gastric neoplasia.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- patients with dyspeptic symptoms and aged 40 years or older

- or patients with Helicobacter pylori infection, or histologically verified gastric intestinal metaplasia or atrophic gastritis

- or patients with family history of gastric cancer

Exclusion Criteria:

- presence of gastrectomy, acute gastrointestinal bleeding, or known gastric neoplasia

- presence of conditions unsuitable for endoscopy procedure including coagulopathy, impaired cardiopulmonary function , pregnancy or breastfeeding

- inability to provide informed consent

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
China Department of Gastroenterology, Qilu Hospital, Shandong University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity of optical enhancement endoscopy in diagnosis of gastric neoplasia 8 months No
Primary Specificity of optical enhancement endoscopy in diagnosis of gastric neoplasia 8 months No
Primary Positive predictive value of optical enhancement endoscopy in diagnosis of gastric neoplasia 8 months No
Primary Negative predictive value of optical enhancement endoscopy in diagnosis of gastric neoplasia 8 months No
Secondary The inter-observer and intra-observer agreement of optic enhancement endoscopy in gastric neoplasia 8 months No
See also
  Status Clinical Trial Phase
Recruiting NCT02063932 - Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal Microbiome N/A